Reason for request
Inclusion on the list of medicines approved for hospital use.
The actual benefit of this medicinal product is substantial.
Clinical Added Value
BERINERT provides a moderate improvement in actual benefit (IAB III) in terms of effectiveness in managing episodes of hereditary angioedema in adults and children.
Évaluation des médicaments